AP

Accenture PLC

Long-term holder

Total reported value

Reporting period: 2024-09-30 · Number of holdings: 1

ACCENTURE PLC disclosed 1 holdings in its latest 13F filing for the period ending 2024-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
0
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
2
Sizing Uniformity

Recent moves

No holding changes this quarter

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1Ikena Oncology INCStock-Other

Holding changes this quarter

Position changes disclosed by Accenture PLC for the quarter ending 2024-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction

FAQ

What is Accenture PLC and what type of investor is it?
Accenture PLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2024-09-30), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Accenture PLC's largest equity positions?
Based on the latest 13F filing, Accenture PLC's top holdings by market value are: 1. Ikena Oncology INC — $0.0
What changes did Accenture PLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Accenture PLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Accenture PLC focus on?
Sector breakdown data is not yet available for Accenture PLC. Check back after the next 13F processing cycle.